Alcohol activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells

被引:91
作者
Masamune, A [1 ]
Kikuta, K [1 ]
Satoh, M [1 ]
Satoh, A [1 ]
Shimosegawa, T [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
D O I
10.1124/jpet.302.1.36
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alcohol is a major cause of both acute and chronic pancreatitis. Activated pancreatic stellate cells (PSCs) have recently been implicated in the pathogenesis of pancreatic inflammation and fibrosis. Herein, we examined the effect of ethanol and acetaldehyde on the activation of transcription factors and mitogen-activated protein (MAP) kinases in PSCs. PSCs were isolated from rat pancreas tissue and used in their culture-activated, myofibroblast-like phenotype. PSCs were treated with ethanol and acetaldehyde at clinically relevant concentrations (50 mM and 200 muM, respectively). Ethanol and acetaldehyde activated activator protein-1 but not nuclear factor-kappaB. In addition, they activated three classes of MAP kinases: extracellular signal-regulated kinase 1/2, c-Jun N-terminal kinase/stress-activated protein kinase, and p38 MAP kinase. Ethanol- and acetaldehyde-induced activation of activator protein-1 and MAP kinases was blocked by the antioxidant N-acetyl-cysteine, suggesting a role of oxidative stress in the signal transduction. Ethanol and acetaldehyde induced alpha1( I) procollagen gene expression but did not induce intercellular adhesion molecule-1 and monocyte chemoattractant protein-1. The acetaldehyde-induced increase of alpha1( I) procollagen gene expression was inhibited by the p38 MAP kinase inhibitor 4-(4- fluorophenyl)-2(4- methylsulfinylphenyl)-5-(4-pyridyl) imidazole (SB203580) but not by the MAP kinase inhibitor 2'-amino-3'-methoxyflavone (PD98059). Specific activation of these signal transduction pathways may play a role in the pathogenesis of alcohol-induced pancreatic injury.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 50 条
  • [21] Mitogen-activated protein kinases in the heart
    Michel, MC
    Li, Y
    Heusch, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (03) : 245 - 266
  • [22] Angiotensin II activates mitogen-activated protein kinases and stimulates growth in rat medullary astrocytes
    Clark, MA
    Landrum, MH
    Tallant, EA
    FASEB JOURNAL, 2001, 15 (05) : A1169 - A1169
  • [23] CHOLECYSTOKININ RAPIDLY ACTIVATES MITOGEN-ACTIVATED PROTEIN-KINASE IN RAT PANCREATIC ACINI
    DUAN, RD
    WILLIAMS, JA
    AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03): : G401 - G408
  • [24] Mitogen-activated protein kinases in atherosclerosis
    Bryk, Dorota
    Olejarz, Wioletta
    Zapolska-Downar, Danuta
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2014, 68 : 10 - 22
  • [25] Mitogen-activated protein kinases in schizophrenia
    Kyosseva, SV
    Elbein, AD
    Griffin, WST
    Mrak, RE
    Lyon, M
    Karson, CN
    BIOLOGICAL PSYCHIATRY, 1999, 46 (05) : 689 - 696
  • [26] Mitogen-activated protein kinases and asthma
    Pelaia, G
    Cuda, G
    Vatrella, A
    Gallelli, L
    Caraglia, M
    Marra, M
    Abbruzzese, A
    Caputi, M
    Maselli, R
    Costanzo, FS
    Marsico, SA
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 202 (03) : 642 - 653
  • [27] Mitogen-activated protein kinases in the heart
    Martin C. Michel
    Yan Li
    Gerd Heusch
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2001, 363 : 245 - 266
  • [28] CHOLECYSTOKININ RAPIDLY ACTIVATES MITOGEN-ACTIVATED PROTEIN-KINASE IN RAT PANCREATIC ACINI
    DUAN, RD
    WILLIAMS, JA
    GASTROENTEROLOGY, 1994, 106 (04) : A291 - A291
  • [29] Ziram activates mitogen-activated protein kinases and decreases cytolytic protein levels in human natural killer cells
    Taylor, Thyneice R.
    Whalen, Margaret M.
    TOXICOLOGY MECHANISMS AND METHODS, 2011, 21 (08) : 577 - 584
  • [30] Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells
    Masamune, A
    Satoh, M
    Kikuta, K
    Sakai, Y
    Satoh, A
    Shimosegawa, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (01) : 8 - 14